Jacobs Levy Equity Management
ELGX

Jacobs Levy Equity Management’s Endologix Inc ELGX Stock Holding History

Jacobs Levy Equity Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-246,936
Closed -$390K – 1159
2019
Q4 		$390K Buy
246,936
+124,894
+102% +$349K ﹤0.01% 818
2019
Q3 		$485K Buy
122,042
+61,875
+103% +$360K 0.01% 722
2019
Q2 		$436K Sell
60,167
-49,036
-45% -$335K 0.01% 760
2019
Q1 		$722K Buy
109,203
+44,548
+69% +$294K 0.01% 725
2018
Q4 		$463K Buy
64,655
+26,702
+70% +$297K 0.01% 744
2018
Q3 		$725K Buy
+37,953
New +$1.35M 0.01% 708

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Jacobs Levy Equity Management's ELGX Position: Q1 2020 in Review

Jacobs Levy Equity Management sold out of Endologix Inc (ELGX) in Q1 2020, closing a stake of 246,936 shares — an estimated $390K sold.

Jacobs Levy Equity Management first reported a position in ELGX in Q3 2018 and held it in 6 quarters. The position peaked at $725K in Q3 2018. 50 funds tracked by Wall St. Rank hold ELGX as of Q1 2020.

  • Jacobs Levy Equity Management reported no remaining Endologix Inc position as of Q1 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 246,936 Endologix Inc shares in Q1 2020, an estimated $390K.
  • Jacobs Levy Equity Management first reported a position in Endologix Inc in Q3 2018 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Endologix Inc position peaked at $725K in Q3 2018.
  • 50 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.